Skip to Main Content

Author Details

Byung Ha Chung
Yonsei University College of Medicine and Gangnam Severance Hospital
1992
247
30
PMIDPaper TitleJournal TitlePublished Year
36858151Deep, rapid, and durable prostate-specific antigen decline with apalutamide plus androgen deprivation therapy is associated with longer survival and improved clinical outcomes in TITAN patients with metastatic castration-sensitive prostate cancer.Ann Oncol2023
37668202A prospective, multicenter study on the clinical effectiveness of abiraterone in metastatic castration-resistant prostate cancer in Korea: Pre- vs. post-chemotherapy.Investig Clin Urol2023
37322621Apalutamide for metastatic castration-sensitive prostate cancer: final analysis of the Asian subpopulation in the TITAN trial.Asian J Androl2023
37076338Toward Precision Medicine: Development and Validation of A Machine Learning Based Decision Support System for Optimal Sequencing in Castration-Resistant Prostate Cancer.Clin Genitourin Cancer2023
37401026Comprehensive Analysis of Individual Anatomical Structures for Micturition Symptoms and Maximum Flow Rate in Men With Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms.Int Neurourol J2023
34259202Apalutamide for patients with metastatic castrationsensitive prostate cancer in East Asia: a subgroup analysis of the TITAN trial.Asian J Androl2022
36477667Role of the elastography strain ratio using transrectal ultrasonography in the diagnosis of prostate cancer and clinically significant prostate cancer.Sci Rep2022
36525150Patients' self-management of adverse events and patient-reported outcomes in advanced renal cell carcinoma treated with targeted therapies: A prospective, longitudinal, observational study.J Patient Rep Outcomes2022
36209207Optical genome mapping identifies clinically relevant genomic rearrangements in prostate cancer biopsy sample.Cancer Cell Int2022
36309672Usefulness of grayscale values of hypoechoic lesions matched with target lesions observed on magnetic resonance imaging for the prediction of clinically significant prostate cancer.BMC Urol2022
36271252Deep learning diagnostics for bladder tumor identification and grade prediction using RGB method.Sci Rep2022
35031671Pain control according to the periprostatic nerve block site in magnetic resonance imaging/transrectal targeted prostate biopsy.Sci Rep2022
33478345Development and Validation of the Stent Tracking Algorithm Registry for Monitoring and Retrieving Forgotten Ureteral Stents.J Endourol2021
33914595Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study.J Clin Oncol2021
34851999Development of prediction models of spontaneous ureteral stone passage through machine learning: Comparison with conventional statistical analysis.PLoS One2021
35059354Pain relieving effect of music on patients during transrectal ultrasonography: A pilot study.Prostate Int2021
34530801Efficacy of additional periprostatic apex nerve block on pain in each of 12 transrectal prostate core biopsies: a retrospective study.BMC Urol2021
34387041Effect of training and individual operator's expertise on prostate cancer detection through prostate biopsy: Implications for the current quantitative training evaluation system.Investig Clin Urol2021
34387040Optimal duration of preoperative antibiotic treatment prior to ureteroscopic lithotripsy to prevent postoperative systemic inflammatory response syndrome in patients presenting with urolithiasis-induced obstructive acute pyelonephritis.Investig Clin Urol2021
34386451Clinical experience with active surveillance protocol using regular magnetic resonance imaging instead of regular repeat biopsy for monitoring: A study at a high-volume center in Korea.Prostate Int2021
34296946Reply by Authors.J Urol2021
34039013Apalutamide plus Androgen Deprivation Therapy for Metastatic Castration-Sensitive Prostate Cancer: Analysis of Pain and Fatigue in the Phase 3 TITAN Study.J Urol2021
33070560External Validation of the Long Short-Term Memory Artificial Neural Network-Based SCaP Survival Calculator for Prediction of Prostate Cancer Survival.Cancer Res Treat2021
31456018The role of prostatic apex shape in voiding symptoms and urine flow: an exploratory and confirmatory study.World J Urol2020
31783936Impact of Lifestyle Intervention for Patients with Prostate Cancer.Am J Health Behav2020
31868997United in Fight against prOstate cancer (UFO) registry: first results from a large, multi-centre, prospective, longitudinal cohort study of advanced prostate cancer in Asia.BJU Int2020
31925552Long short-term memory artificial neural network model for prediction of prostate cancer survival outcomes according to initial treatment strategy: development of an online decision-making support system.World J Urol2020
31942460Comparison of prostate cancer detection rates of various prostate biopsy methods for patients with prostate-specific antigen levels of <10.0 ng/mL in real-world practice.Investig Clin Urol2020
31942459Enzalutamide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: A retrospective Korean multicenter study in a real-world setting.Investig Clin Urol2020
32734728Optimal PSA Threshold for Androgen-Deprivation Therapy in Patients with Prostate Cancer following Radical Prostatectomy and Adjuvant Radiation Therapy.Yonsei Med J2020
32257971Clinical studies investigating the use of leuprorelin for prostate cancer in Asia.Prostate Int2020
30307365Robot-Assisted Partial Nephrectomy for Totally Endophytic Renal Tumors: Step by Step Standardized Surgical Technique and Long-Term Outcomes with a Median 59-Month Follow-Up.J Laparoendosc Adv Surg Tech A2019
31702677Stratification based on adverse laboratory/pathological features for predicting overall survival in patients undergoing radical prostatectomy: A K-CaP registry-based analysis.Medicine (Baltimore)2019
31692911The association of family history of prostate cancer with the diagnosis of clinically significant prostate cancer in Korean population.Investig Clin Urol2019
31861036Is targeted biopsy really needed when performing systematic prostate biopsy to raise the detection rate for prostate cancer in patients with prostate-specific antigen ⿤10⿿ng/mL?Medicine (Baltimore)2019
31769243Impact of Cerebrovascular Disease on Survival Benefits from Local Treatment in Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer.Yonsei Med J2019
30214035Importance of androgen-deprivation therapy during enzalutamide treatment in men with metastatic castration-resistant prostate cancer following chemotherapy: results from retrospective, multicenter data.Prostate Cancer Prostatic Dis2019
30019467Management of patients with advanced prostate cancer in the Asia Pacific region: 'real-world' consideration of results from the Advanced Prostate Cancer Consensus Conference (APCCC) 2017.BJU Int2019
31438204Development of Integrated Data and Prediction System Platform for the Localized Prostate Cancer.Stud Health Technol Inform2019
31578173Health-related quality of life after apalutamide treatment in patients with metastatic castration-sensitive prostate cancer (TITAN): a randomised, placebo-controlled, phase 3 study.Lancet Oncol2019
31626149Impact of metabolic syndrome-related factors on the development of benign prostatic hyperplasia and lower urinary tract symptoms in Asian population.Medicine (Baltimore)2019
31592197The association of depression with lower urinary tract symptoms: data from the National Health and Nutrition Examination Survey, 2005-2008.PeerJ2019
31417160Effect of Prior Local Treatment and Prostate-Specific Antigen Kinetics during Androgen-Deprivation Therapy on the Survival of Castration-Resistant Prostate Cancer.Sci Rep2019
31045843Predictive factors for the development of renal insufficiency following partial nephrectomy and subsequent renal function recovery: A multicenter retrospective study.Medicine (Baltimore)2019
30894638What is the most effective local anesthesia for transrectal ultrasonography-guided biopsy of the prostate? A systematic review and network meta-analysis of 47 randomized clinical trials.Sci Rep2019
31150574Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer.N Engl J Med2019
30734074Optimal sequencing strategy using docetaxel and androgen receptor axis-targeted agents in patients with castration-resistant prostate cancer: utilization of neutrophil-to-lymphocyte ratio.World J Urol2019
30886549Pathological Characteristics of Prostate Cancer in Men Aged < 50 Years Treated with Radical Prostatectomy: a Multi-Centre Study in Korea.J Korean Med Sci2019
31141613Report of the forth Asian Prostate Cancer (A-CaP) study meeting.Jpn J Clin Oncol2019
31085754Is Primary Androgen Deprivation Therapy a Suitable Option for Asian Patients With Prostate Cancer Compared With Radical Prostatectomy?J Natl Compr Canc Netw2019
  • 1 - 50 of 247

Recommended Authors

Mayo Clinic
Career Start Year 2017
Number of shared co-authors 0
Institute of Cancer Prevention and Treatment, Harbin Medical University
Career Start Year 2015
Number of shared co-authors 1
Glickman Urological & Kidney Institute, Cleveland Clinic
Career Start Year 2013
Number of shared co-authors 0
IRCCS San Raffaele Scientific Institute, Italy Vita-Salute San Raffaele University
Career Start Year 2012
Number of shared co-authors 8
Urological Research Institute, IRCCS San Raffaele Hospital
Career Start Year 2012
Number of shared co-authors 2
university of california san diego School of Medicine
Career Start Year 2011
Number of shared co-authors 1
Columbia University Medical Center
Career Start Year 2010
Number of shared co-authors 0
University of Texas Health San Antonio
Career Start Year 2008
Number of shared co-authors 2
University of Oxford
Career Start Year 2007
Number of shared co-authors 6
University of Washington Medical Center
Career Start Year 2005
Number of shared co-authors 5
University of California San Diego
Career Start Year 2005
Number of shared co-authors 0
Winterthur Cantonal Hospital
Career Start Year 2005
Number of shared co-authors 1
Universitatsklinikum Hamburg-Eppendorf
Career Start Year 2004
Number of shared co-authors 25
IRCCS San Raffaele Scientific Institute
Career Start Year 2002
Number of shared co-authors 26
university of california san diego Moores Cancer Center
Career Start Year 2001
Number of shared co-authors 10
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 2001
Number of shared co-authors 10
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 15
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1997
Number of shared co-authors 9
University of Michigan ann arbor
Career Start Year 1997
Number of shared co-authors 16
Cedars-Sinai Medical Center
Career Start Year 1996
Number of shared co-authors 16
Radboud University Medical Center
Career Start Year 1995
Number of shared co-authors 26
University Health Network, Princess Margaret Cancer Center, University of Toronto
Career Start Year 1993
Number of shared co-authors 7
University Hospital Frankfurt, Goethe University Frankfurt am Main
Career Start Year 1993
Number of shared co-authors 10
University of Toronto
Career Start Year 1989
Number of shared co-authors 14
Liverpool University Hospitals
Career Start Year 1988
Number of shared co-authors 4
The Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year 1987
Number of shared co-authors 11
University of Oxford
Career Start Year 1987
Number of shared co-authors 11
McGill University Health Centre, McGill University
Career Start Year 1987
Number of shared co-authors 7
Johns Hopkins University School of Medicine
Career Start Year 1984
Number of shared co-authors 9
Cleveland Clinic
Career Start Year 1984
Number of shared co-authors 19

Collaborators

Asan Medical Center, University of Ulsan College of Medicine
Co-authored papers 38
Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea
Co-authored papers 30
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 15
Seoul National University Bundang Hospital
Co-authored papers 10
Asan Medical Center, University of Ulsan College of Medicine
Co-authored papers 10
The Catholic University of Korea College of Medicine
Co-authored papers 10
University of British Columbia
Co-authored papers 8
Seoul National University Hospital, Seoul National University College of Medicine
Co-authored papers 6
Co-authored papers 6
Skane University Hospital, Lund University
Co-authored papers 6
Seoul National University Hospital, Seoul National University College of Medicine
Co-authored papers 5
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 4
Seoul National University Bundang Hospital
Co-authored papers 4
Yonsei University College of Medicine, Republic of Korea S. Biomedics Co.
Co-authored papers 4
James Buchanan Brady Urological Institute, Johns Hopkins School of Medicine
Co-authored papers 3
Co-authored papers 3
Peter MacCallum Cancer Centre, University of Melbourne
Co-authored papers 3
University of Texas Health Science Center at Houston
Co-authored papers 2
The Institute of Cancer Research
Co-authored papers 1
University of British Columbia
Co-authored papers 1
The Institute of Cancer Research
Co-authored papers 1
University of Washington, USA Brotman Baty Institute for Precision Medicine
Co-authored papers 1
University of Montreal Health Center
Co-authored papers 1
Houston Methodist Cancer Center
Co-authored papers 1
University of Bern
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
Dana-Farber Cancer Institute
Co-authored papers 1
Tulane University School of Medicine
Co-authored papers 1
Hospitalier Universitaire de Saint-Etienne
Co-authored papers 1
Ghent University, GZA Ziekenhuizen
Co-authored papers 1